Response to Rivastigmine Transdermal Patch or Memantine plus Rivastigmine Patch is affected by Apolipoprotein E Genotype in Alzheimer Patients
Hyun Jeong Han(Kyungdong University), Seong Hye Choi(Inha University), Seung‐Ho Ryu(Konkuk University Medical Center), Mun Seong Choi(Maryknoll Medical Center), Hae Ri Na(Bobath memorial hospital), Kyung Won Park(Dong-A University), Kwang K. Kim(Dongguk University), Soo‐Jin Cho(University of California, San Francisco), Jun‐Young Lee(Seoul National University), Soo Jin Yoon(Eulji University), Hyun Young Park(Dongguk University), Jae‐Hyeok Heo(Seoul Medical Center), Byeong C. Kim(Chonnam National University Hospital), Hyon-Ah Yi(Keimyung University), Joon Hyun Shin(Hallym University)
Cited by 21
Related Papers
Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease
|European Journal of Nuclear Medicine and Molecular Imaging|2008|277
Endovascular Treatment and the Outcomes of Atherosclerotic Intracranial Stenosis in Patients With Hyperacute Stroke
|Neurosurgery|2015|179
Long COVID headache
|The Journal of Headache and Pain|2022|158
Ensembles of Patch-Based Classifiers for Diagnosis of Alzheimer Diseases
|IEEE Access|2019|150